Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 13/20 | 0.35 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.34 |
| ▸ | JAK2 | O60674 | 2/20 | 0.32 |
| ▸ | EIF2AK3 | Q9NZJ5 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | HCK | P08631 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.30 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31728084 | 1.00 | MET (0.35) | METALKJAK2EIF2AK3ABL1 | |
| SCHEMBL31728571 | 0.85 | MET (0.35) | METALKJAK2 | |
| SCHEMBL31729165 | 0.85 | MET (0.35) | METALKJAK2 | |
| SCHEMBL31729300 | 0.84 | MET (0.35) | METALKEIF2AK3ABL1EGFR | |
| SCHEMBL31728112 | 0.84 | MET (0.33) | METALKEIF2AK3ABL1EGFR | |
| SCHEMBL31727950 | 0.84 | MET (0.33) | METALKEIF2AK3ABL1EGFR | |
| SCHEMBL31728507 | 0.82 | MET (0.33) | METALKJAK2EIF2AK3ABL1 | |
| SCHEMBL31727909 | 0.82 | MET (0.33) | METALKJAK2EIF2AK3ABL1 | |
| SCHEMBL31729157 | 0.80 | PDE5A (0.39) | EIF2AK3ABL1EGFRHCKSRC | |
| SCHEMBL31728453 | 0.72 | CLK1 (0.38) | EIF2AK3ABL1EGFRHCKSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235874-A1 | HETEROCYCLICS AS EGFR INHIBITORS | SCHRÖDINGER, INC. (US) | 2025-11-13 | — | — | WO | disclosed |